MXPA03007777A - Composicion acuosa de anfotericina b. - Google Patents

Composicion acuosa de anfotericina b.

Info

Publication number: MXPA03007777A
Authority: MX; Mexico
Prior art keywords: amphotericin; compositions; aqueous composition; autoclaving; phospholipids
Prior art date: 2001-03-01

Application number

MXPA03007777A

Other languages

English (en)

Inventor

Pai Srikanth

Original Assignee

Bharat Serums & Vaccines Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-03-01

Filing date

2001-03-16

Publication date

2003-12-08

2001-03-16 Application filed by Bharat Serums & Vaccines Ltd filed Critical Bharat Serums & Vaccines Ltd

2003-12-08 Publication of MXPA03007777A publication Critical patent/MXPA03007777A/es

Links

239000000203 mixture Substances 0.000 title abstract 6
APKFDSVGJQXUKY-KKGHZKTASA-N Amphotericin-B Natural products O[C@H]1[C@@H](N)[C@H](O)[C@@H](C)O[C@H]1O[C@H]1C=CC=CC=CC=CC=CC=CC=C[C@H](C)[C@@H](O)[C@@H](C)[C@H](C)OC(=O)C[C@H](O)C[C@H](O)CC[C@@H](O)[C@H](O)C[C@H](O)C[C@](O)(C[C@H](O)[C@H]2C(O)=O)O[C@H]2C1 APKFDSVGJQXUKY-KKGHZKTASA-N 0.000 title abstract 4
APKFDSVGJQXUKY-INPOYWNPSA-N amphotericin B Chemical compound O[C@H]1[C@@H](N)[C@H](O)[C@@H](C)O[C@H]1O[C@H]1/C=C/C=C/C=C/C=C/C=C/C=C/C=C/[C@H](C)[C@@H](O)[C@@H](C)[C@H](C)OC(=O)C[C@H](O)C[C@H](O)CC[C@@H](O)[C@H](O)C[C@H](O)C[C@](O)(C[C@H](O)[C@H]2C(O)=O)O[C@H]2C1 APKFDSVGJQXUKY-INPOYWNPSA-N 0.000 title abstract 4
229960003942 amphotericin b Drugs 0.000 title abstract 4
IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 abstract 2
FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 abstract 2
208000037026 Invasive Fungal Infections Diseases 0.000 abstract 1
231100000053 low toxicity Toxicity 0.000 abstract 1
150000003904 phospholipids Chemical class 0.000 abstract 1
239000011780 sodium chloride Substances 0.000 abstract 1
239000002904 solvent Substances 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Epidemiology (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
Molecular Biology (AREA)
Biophysics (AREA)
Dispersion Chemistry (AREA)
Engineering & Computer Science (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Oil, Petroleum & Natural Gas (AREA)
Dermatology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Saccharide Compounds (AREA)
Medicinal Preparation (AREA)
Agricultural Chemicals And Associated Chemicals (AREA)

MXPA03007777A 2001-03-01 2001-03-16 Composicion acuosa de anfotericina b. MXPA03007777A (es)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
IN217MU2001 IN188924B (es)	2001-03-01	2001-03-01
PCT/IN2001/000040 WO2002069983A1 (en)	2001-03-01	2001-03-16	Amphotericin b aqueous composition

Publications (1)

Publication Number	Publication Date
MXPA03007777A true MXPA03007777A (es)	2003-12-08

Family

ID=11097223

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
MXPA03007777A MXPA03007777A (es)	2001-03-01	2001-03-16	Composicion acuosa de anfotericina b.

Country Status (23)

Country	Link
US (1)	US20040137049A1 (es)
EP (1)	EP1368041B1 (es)
JP (1)	JP2004523566A (es)
KR (1)	KR100810067B1 (es)
CN (1)	CN1255114C (es)
AT (1)	ATE274913T1 (es)
AU (1)	AU2001250643B2 (es)
BG (1)	BG108188A (es)
BR (1)	BR0116922A (es)
CA (1)	CA2438847A1 (es)
CZ (1)	CZ20032264A3 (es)
DE (1)	DE60105322T2 (es)
DK (1)	DK1368041T3 (es)
EA (1)	EA006241B1 (es)
ES (1)	ES2227172T3 (es)
IN (1)	IN188924B (es)
MX (1)	MXPA03007777A (es)
NZ (1)	NZ528281A (es)
PT (1)	PT1368041E (es)
SK (1)	SK10742003A3 (es)
WO (1)	WO2002069983A1 (es)
YU (1)	YU75403A (es)
ZA (1)	ZA200307307B (es)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US7731947B2 (en)	2003-11-17	2010-06-08	Intarcia Therapeutics, Inc.	Composition and dosage form comprising an interferon particle formulation and suspending vehicle
JP2006069929A (ja) *	2004-08-31	2006-03-16	Konica Minolta Medical & Graphic Inc	真菌症治療製剤およびその製造方法
WO2006030450A2 (en) *	2004-09-13	2006-03-23	Bharat Serums & Vaccines Ltd.	Stable emulsion compositions for intravenous administration having antimicrobial preservative efficacy
US11246913B2 (en)	2005-02-03	2022-02-15	Intarcia Therapeutics, Inc.	Suspension formulation comprising an insulinotropic peptide
WO2006083761A2 (en)	2005-02-03	2006-08-10	Alza Corporation	Solvent/polymer solutions as suspension vehicles
CN100418536C (zh) *	2005-04-06	2008-09-17	河南省眼科研究所	一种用于眼科的抗真菌药物组合物
CN101453982B (zh)	2006-05-30	2011-05-04	精达制药公司	两件式内部通道渗透递送系统流动调节器
DK2359808T3 (da)	2006-08-09	2013-08-05	Intarcia Therapeutics Inc	Osmotiske leveringssystemer og stempelaggregater
EP2157967B1 (en)	2007-04-23	2013-01-16	Intarcia Therapeutics, Inc	Suspension formulations of insulinotropic peptides and uses thereof
EP2240155B1 (en)	2008-02-13	2012-06-06	Intarcia Therapeutics, Inc	Devices, formulations, and methods for delivery of multiple beneficial agents
DK2462246T3 (da)	2009-09-28	2017-11-06	Intarcia Therapeutics Inc	Hurtig etablering og/eller afslutning af væsentlig steady-state-lægemiddelafgivelse
KR101629521B1 (ko) *	2010-03-16	2016-06-13	우석대학교 산학협력단	난용성 약물 가용화 및 생체막 투과증진을 위한 알코올성 수상을 내상으로 하는 리포좀, 리포좀 조성물 및 리포좀의 제조방법
US20120208755A1 (en)	2011-02-16	2012-08-16	Intarcia Therapeutics, Inc.	Compositions, Devices and Methods of Use Thereof for the Treatment of Cancers
CN102525921B (zh) *	2012-02-06	2013-08-07	西安力邦制药有限公司	2,2’,6,6’-四异丙基-4,4’-二联苯酚脂微球制剂及其制备方法
WO2013142184A1 (en) *	2012-03-19	2013-09-26	Yale University	Antimicrobial compositions and methods
US9889085B1 (en)	2014-09-30	2018-02-13	Intarcia Therapeutics, Inc.	Therapeutic methods for the treatment of diabetes and related conditions for patients with high baseline HbA1c
EP3302354B1 (en)	2015-06-03	2023-10-04	i2o Therapeutics, Inc.	Implant placement systems
EP3222324B1 (en)	2016-03-23	2020-05-13	Wayne State University	Valproate as a topical anti-fungal treatment
MA53353A (fr)	2016-05-16	2021-06-09	Intarcia Therapeutics Inc	Polypeptides sélectifs pour le récepteur du glucagon et méthodes pour leur utilisation
USD860451S1 (en)	2016-06-02	2019-09-17	Intarcia Therapeutics, Inc.	Implant removal tool
USD840030S1 (en)	2016-06-02	2019-02-05	Intarcia Therapeutics, Inc.	Implant placement guide
KR20190104039A (ko)	2017-01-03	2019-09-05	인타르시아 세라퓨틱스 인코포레이티드	Glp-1 수용체 효능제의 연속적인 투여 및 약물의 동시-투여를 포함하는 방법
CN108344811A (zh) *	2017-01-24	2018-07-31	北京泰德制药股份有限公司	一种注射用脂质体中有机溶剂残留的检测方法
CN108309955B (zh) *	2018-04-27	2020-06-02	武昌理工学院	一种聚明胶肽结合型紫杉醇纳米颗粒的制备方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CA1338736C (fr) *	1986-12-05	1996-11-26	Roger Baurain	Microcristaux comportant une substance active presentant une affinite pour les phospholipides, et au moins un phospholipide, procede de preparation
US5616334A (en) *	1987-03-05	1997-04-01	The Liposome Company, Inc.	Low toxicity drug-lipid systems
US5100662A (en) *	1989-08-23	1992-03-31	The Liposome Company, Inc.	Steroidal liposomes exhibiting enhanced stability
FR2651680B1 (fr) *	1989-09-14	1991-12-27	Medgenix Group Sa	Nouveau procede de preparation de microparticules lipidiques.
US5580575A (en) *	1989-12-22	1996-12-03	Imarx Pharmaceutical Corp.	Therapeutic drug delivery systems
JP3956402B2 (ja) *	1996-03-04	2007-08-08	日本油脂株式会社	アンホテリシンｂ運搬体
US6180136B1 (en) *	1998-11-10	2001-01-30	Idexx Laboratories, Inc.	Phospholipid-coated microcrystals for the sustained release of pharmacologically active compounds and methods of their manufacture and use

2001
- 2001-03-01 IN IN217MU2001 patent/IN188924B/en unknown
- 2001-03-16 DE DE60105322T patent/DE60105322T2/de not_active Expired - Lifetime
- 2001-03-16 PT PT01923963T patent/PT1368041E/pt unknown
- 2001-03-16 AU AU2001250643A patent/AU2001250643B2/en not_active Ceased
- 2001-03-16 JP JP2002569158A patent/JP2004523566A/ja active Pending
- 2001-03-16 ES ES01923963T patent/ES2227172T3/es not_active Expired - Lifetime
- 2001-03-16 CN CNB018231632A patent/CN1255114C/zh not_active Expired - Fee Related
- 2001-03-16 WO PCT/IN2001/000040 patent/WO2002069983A1/en active IP Right Grant
- 2001-03-16 BR BR0116922-0A patent/BR0116922A/pt active Search and Examination
- 2001-03-16 CA CA002438847A patent/CA2438847A1/en not_active Abandoned
- 2001-03-16 KR KR1020037011489A patent/KR100810067B1/ko not_active IP Right Cessation
- 2001-03-16 SK SK1074-2003A patent/SK10742003A3/sk unknown
- 2001-03-16 DK DK01923963T patent/DK1368041T3/da active
- 2001-03-16 US US10/469,624 patent/US20040137049A1/en not_active Abandoned
- 2001-03-16 CZ CZ20032264A patent/CZ20032264A3/cs unknown
- 2001-03-16 EP EP01923963A patent/EP1368041B1/en not_active Expired - Lifetime
- 2001-03-16 NZ NZ528281A patent/NZ528281A/en not_active IP Right Cessation
- 2001-03-16 EA EA200300948A patent/EA006241B1/ru not_active IP Right Cessation
- 2001-03-16 MX MXPA03007777A patent/MXPA03007777A/es active IP Right Grant
- 2001-03-16 AT AT01923963T patent/ATE274913T1/de not_active IP Right Cessation
- 2001-03-16 YU YU75403A patent/YU75403A/sh unknown
2003
- 2003-09-18 ZA ZA200307307A patent/ZA200307307B/en unknown
- 2003-09-23 BG BG108188A patent/BG108188A/bg unknown

Also Published As

Publication number	Publication date
DE60105322D1 (de)	2004-10-07
EP1368041A1 (en)	2003-12-10
WO2002069983A1 (en)	2002-09-12
ZA200307307B (en)	2004-04-20
ES2227172T3 (es)	2005-04-01
YU75403A (sh)	2006-05-25
EA006241B1 (ru)	2005-10-27
KR20040018337A (ko)	2004-03-03
CZ20032264A3 (cs)	2003-12-17
EA200300948A1 (ru)	2004-04-29
CA2438847A1 (en)	2002-09-12
BG108188A (bg)	2004-09-30
JP2004523566A (ja)	2004-08-05
PT1368041E (pt)	2005-01-31
EP1368041B1 (en)	2004-09-01
CN1505519A (zh)	2004-06-16
AU2001250643B2 (en)	2007-03-22
US20040137049A1 (en)	2004-07-15
BR0116922A (pt)	2004-04-27
ATE274913T1 (de)	2004-09-15
DK1368041T3 (da)	2005-01-17
NZ528281A (en)	2006-11-30
CN1255114C (zh)	2006-05-10
IN188924B (es)	2002-11-23
KR100810067B1 (ko)	2008-03-05
SK10742003A3 (sk)	2004-01-08
DE60105322T2 (de)	2005-09-15

Publication	Publication Date	Title
MXPA03007777A (es)	2003-12-08	Composicion acuosa de anfotericina b.
WO2001092288A3 (en)	2002-06-27	Cobalamin compounds useful as antibiotic agents and as imaging agents
CA2292359A1 (en)	2000-07-28	Novel azalides and methods of making same
BR0112461A (pt)	2003-07-22	Composições que contém componentes terapeuticamente ativos tendo uma solubilidade aumentada
SI1458360T1 (sl)	2011-08-31	Pulmonalno dajanje aminoglikozidov
MX2007010072A (es)	2008-01-28	Derivados de piperidina antibacterianos.
WO2003010138A3 (en)	2003-12-04	Piperidine derivatives as antibacterial agents
BG104644A (en)	2001-01-31	Novel macrolides
EP1075837A3 (en)	2001-05-16	Process for the preparation of aqueous formulations for ophthalmic use
ES2187300A1 (es)	2003-05-16	Derivados de sulfonamidas, su preparacion y su aplicacion como medicamentos.
BG106366A (en)	2002-08-30	Moxifloxacin formulation containing common salt
UA88463C2 (ru)	2009-10-26	Фармацевтическая композиция, которая содержит соединение 1, и процесс лечения вич-инфекции
CY1110664T1 (el)	2015-06-10	Ενδορινικες συνθεσετς
IL171653A (en)	2013-06-27	History of aminocyclohexyl ether and pharmacy preparations containing them
MXPA03010761A (es)	2004-03-02	Combinaciones farmaceuticas.
TNSN04034A1 (en)	2006-06-01	Combined preparations, containing 1,4-benzothiepine-1,1-dioxide derivatives and other active substances, and the use thereof
WO2003082268A3 (en)	2004-09-23	Hemiasterlin derivatives and uses thereof in the treatment of cancer
ES2186550A1 (es)	2003-05-01	Nuevos derivados de oxazolidinonas como antibacterianos.
MXPA04006041A (es)	2004-09-27	Antivirales de piridoquinoxalina.
WO2003090744A8 (en)	2004-03-18	Antibacterial compositions comprising metal phthalocyanine analogues
WO2005030794A3 (en)	2005-08-18	Hemiasterlin derivatives and uses thereof
WO2002072581A3 (en)	2003-05-01	Pyrazolopyriadine derivatives
AU2002357740A1 (en)	2003-06-23	Pyrazolo-pyridine derivatives as antiherpes agents
EP1411956B8 (en)	2005-10-05	Use of oversulfated polysaccharides as inhibitors of hiv
CY1106711T1 (el)	2012-05-23	Υποκατεστημενα παραγωγα προπανο-1,3-διαμινης και η φαρμακευτικη χρηση τους

Legal Events

Date	Code	Title	Description
2006-09-28	FG	Grant or registration